Zule William A, Oramasionwu Christine, Evon Donna, Hino Sayaka, Doherty Irene A, Bobashev Georgiy V, Wechsberg Wendee M
a Substance Abuse Treatment Evaluations and Interventions Program, RTI International , Research Triangle Park , NC , USA.
b UNC Eshelman School of Pharmacy , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
Am J Drug Alcohol Abuse. 2016 Nov;42(6):689-697. doi: 10.1080/00952990.2016.1174706. Epub 2016 Jun 10.
BACKGROUND: Nonmedical prescription opioid use has been linked to hepatitis C virus (HCV) infection among people who inject drugs and with using high dead space syringes that retain more blood and transfer more HIV if shared. Little is known regarding its effects on sex-risk behaviors. OBJECTIVES: This paper examines event-level associations between nonmedical prescription opioid use and sharing high dead space syringes (injection risk) and unprotected intercourse (sex risk) behaviors. METHODS: We recruited 1,985 participants from two overlapping risk groups-drug users and men who have sex with men (MSM)-and their sex partners. Participants completed an interview that included event-level sex questions with recent sex partners and injection questions with recent injection partners. We used multivariable generalized estimating equations (GEE) to assess the associations between nonmedical prescription opioid use and unprotected intercourse during sexual encounters and sharing syringes during injection episodes, while adjusting for within-person correlations. RESULTS: When both partners used nonmedical prescription opioids, its use was independently associated with unprotected intercourse in sexual encounters (OR = 2.24; 95% CI = 1.12, 4.49). The use of nonmedical prescription opioids was also associated with sharing high dead space syringes during injection episodes (OR = 6.57; 95% CI = 1.63, 26.51). CONCLUSION: Nonmedical prescription opioid use is associated with an increase in the risk of unprotected sex and sharing high dead space syringes. HIV and HCV prevention interventions for nonmedical prescription opioid users should address sex-risk behaviors and encourage the use of acceptable low dead space needles and syringes.
背景:非医疗用途的处方阿片类药物使用与注射吸毒者中的丙型肝炎病毒(HCV)感染有关,也与使用死腔大的注射器有关,这种注射器会残留更多血液,若共用则会传播更多艾滋病毒。关于其对性风险行为的影响知之甚少。 目的:本文研究非医疗用途的处方阿片类药物使用与共用死腔大的注射器(注射风险)和无保护性交(性风险)行为之间的事件层面关联。 方法:我们从两个重叠的风险群体——吸毒者和男男性行为者(MSM)及其性伴侣中招募了1985名参与者。参与者完成了一项访谈,其中包括与近期性伴侣有关的事件层面性问题以及与近期注射伙伴有关的注射问题。我们使用多变量广义估计方程(GEE)来评估非医疗用途的处方阿片类药物使用与性接触期间的无保护性交以及注射期间共用注射器之间的关联,同时调整个体内相关性。 结果:当双方都使用非医疗用途的处方阿片类药物时,其使用与性接触中的无保护性交独立相关(比值比[OR]=2.24;95%置信区间[CI]=1.12,4.49)。非医疗用途的处方阿片类药物使用也与注射期间共用死腔大的注射器有关(OR=6.57;95%CI=1.63,2,651)。 结论:非医疗用途的处方阿片类药物使用与无保护性行为和共用死腔大的注射器风险增加有关。针对非医疗用途的处方阿片类药物使用者的艾滋病毒和丙型肝炎病毒预防干预措施应解决性风险行为问题,并鼓励使用可接受的死腔小的针头和注射器。
Am J Drug Alcohol Abuse. 2016-11
Int J Drug Policy. 2015-4
AIDS Behav. 2013-3
Infect Dis Ther. 2020-12
Addict Sci Clin Pract. 2020-6-19
Mol Pain. 2020
Int J Drug Policy. 2015-12
Annu Rev Public Health. 2015-1-12
JAMA Psychiatry. 2014-7-1
Pharmacoepidemiol Drug Saf. 2014-3
Am J Public Health. 2014-3-13